Active surveillance for favorable risk prostate cancer.
Department of Urology, The Johns Hopkins University School of Medicine, The James Buchanan Brady Urological Institute, Johns Hopkins Hospital, Baltimore, Maryland, USA.
H Ballentine
HB
Carter
D037001:Directive Counseling; D018450:Disease Progression; D006801:Humans; D008297:Male; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000453:epidemiology; D057832:Watchful Waiting
D017430:Prostate-Specific Antigen